Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–55.
Article CAS PubMed Google Scholar
Moschino L, Bonadies L, Baraldi E. Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56:3499–508.
Article PubMed PubMed Central Google Scholar
Jo HS, Cho KH, Cho S-I, Song ES, Kim B, Il. Recent changes in the incidence of Bronchopulmonary Dysplasia among very-low-birth-weight infants in Korea. J Korean Med Sci. 2015;30:S81–7.
Article PubMed PubMed Central Google Scholar
Gilfillan MA, Mejia MJ, Bhandari V. Prevalence, Prevention and Management of Bronchopulmonary Dysplasia. Res Rep Neonatol. 2024;14:1–33.
Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European Consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120:3–23.
Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, et al. Bronchopulmonary dysplasia. Nat Rev Dis Prim. 2019;5:78.
Wozniak PS, Moallem M, Sánchez PJ. Infection and inflammation: catalysts of Pulmonary Morbidity in Bronchopulmonary Dysplasia. In: Hibbs AM, Muhlebach MS, editors. Respir outcomes Preterm infants. Springer International Publishing AG; 2017. pp. 215–29.
Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Bührer C, et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J Engl. 2013;41:966–73.
Rehan VK, Wang Y, Patel S, Santos J, Torday JS. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol. 2006;41:558–69.
Nardiello C, Mižíková I, Silva DM, Ruiz-Camp J, Mayer K, Vadász I, et al. Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia. Dis Model Mech. 2017;10:185–96.
CAS PubMed PubMed Central Google Scholar
Sakurai R, Villarreal P, Husain S, Liu J, Sakurai T, Tou E, et al. Curcumin protects the developing lung against long-term hyperoxic injury. Am J Physiol - Lung Cell Mol Physiol. 2013;305:L301–11.
Article CAS PubMed PubMed Central Google Scholar
Seedorf G, Kim C, Wallace B, Mandell EW, Nowlin T, Shepherd D, et al. rhIGF-1/BP3 preserves lung growth and prevents pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201:1120–34.
Article CAS PubMed PubMed Central Google Scholar
Lee HJ, Lee YJ, Choi CW, Lee JA, Kim EK, Kim HS, et al. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia. Yonsei Med J. 2014;55:99–106.
Article CAS PubMed Google Scholar
Mandell E, Seedorf G, Gien J, Abman SH. Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol - Lung Cell Mol Physiol. 2014;306(5):L420–8.
Article CAS PubMed Google Scholar
Salaets T, Gie A, Tack B, Deprest J, Toelen J. Modelling bronchopulmonary dysplasia in animals: arguments for the Preterm rabbit model. Curr Pharm Des United Arab Emirates. 2017;23:5887–901.
Papagianis PC, Noble PB, Ahmadi-Noorbakhsh S, Savigni D, Moss TJM, Pillow JJ. Postnatal steroids as lung protective and anti-inflammatory in preterm lambs exposed to antenatal inflammation. Pediatr Res. 2024;95:931–40.
Article CAS PubMed Google Scholar
Albertine KH, Dahl MJ, Rebentisch A, Dawson E, Nabi A, Bowen S, et al. Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia. Pediatr Res. 2023;93:1528–38.
Article CAS PubMed Google Scholar
Albertine KH, Rebentisch A, Dawson E, Van Boerum J, Major E, Štipka J, et al. Mesenchymal stromal cell extracellular vesicles improve lung development in mechanically ventilated preterm lambs. Am J Physiol Cell Mol Physiol. 2024;326:L770–85.
Choi YJ, Williams E, Dahl MJ, Amos SE, James C, Bautista AP, et al. Antenatal creatine supplementation reduces persistent fetal lung inflammation and oxidative stress in an ovine model of chorioamnionitis. Am J Physiol Cell Mol Physiol. 2024;327:L40–53.
Albertine KH, Dahl MJ, Gonzales LW, Wang ZM, Metcalfe D, Hyde DM, et al. Chronic lung disease in preterm lambs: Effect of daily vitamin A treatment on alveolarization. Am J Physiol - Lung Cell Mol Physiol. 2010;299:L59–72.
Article CAS PubMed PubMed Central Google Scholar
Caminita F, van der Merwe M, Hance B, Krishnan R, Miller S, Buddington K, et al. A preterm pig model of lung immaturity and spontaneous infant respiratory distress syndrome. Am J Physiol - Lung Cell Mol Physiol. 2015;308:L118–29.
Article CAS PubMed Google Scholar
Song Y, Dahl MJ, Leavitt W, Alvord J, Bradford CY, Albertine KH, et al. Vitamin a protects the preterm lamb diaphragm against adverse effects of mechanical ventilation. Front Physiol. 2018;9:1–13.
Yoder BA, Coalson JJ. Animal models of bronchopulmonary dysplasia. The preterm baboon models. Am J Physiol Cell Mol Physiol. 2014;307:L970–7.
Salaets T, Aertgeerts M, Gie A, Vignero J, de Winter D, Regin Y, et al. Preterm birth impairs postnatal lung development in the neonatal rabbit model. Respir Res. 2020;21:59.
Article CAS PubMed PubMed Central Google Scholar
Salaets T, Tack B, Jimenez J, Gie A, Lesage F, de Winter D, et al. Simvastatin attenuates lung functional and vascular effects of hyperoxia in preterm rabbits. Pediatr Res. 2020;87:1193–200.
Article CAS PubMed Google Scholar
Aquila G, Regin Y, Murgia X, Salomone F, Casiraghi C, Catozzi C, et al. Daily Intraperitoneal Administration of Rosiglitazone does not improve lung function or alveolarization in Preterm rabbits exposed to Hyperoxia. Pharmaceutics. 2022;14:1507.
Article CAS PubMed PubMed Central Google Scholar
Gie AG, Regin Y, Salaets T, Casiraghi C, Salomone F, Deprest J, et al. Intratracheal budesonide/surfactant attenuates hyperoxia-induced lung injury in preterm rabbits. Am J Physiol Cell Mol Physiol. 2020;319:L949–56.
Richter J, Jimenez J, Nagatomo T, Toelen J, Brady P, Salaets T, et al. Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury. J Transl Med. 2016;14:247.
Article PubMed PubMed Central Google Scholar
Dahl MJ, Bowen S, Aoki T, Rebentisch A, Dawson E, Pettet L, et al. Former-preterm lambs have persistent alveolar simplification at 2 and 5 months corrected postnatal age. Am J Physiol Cell Mol Physiol. 2018;315:L816–33.
Dahl MJ, Veneroni C, Lavizzari A, Bowen S, Emerson H, Rebentisch A, et al. Early extubation to noninvasive respiratory support of former preterm lambs improves long-term respiratory outcomes. Am J Physiol Cell Mol Physiol. 2021;321:L248–62.
Nold MF, Mangan NE, Rudloff I, Cho SX, Shariatian N, Samarasinghe TD, et al. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc Natl Acad Sci. 2013;110:14384–9.
Article CAS PubMed PubMed Central Google Scholar
Manzano RM, Mascaretti RS, Carrer V, Haddad LB, Fernandes AR, Reyes AMA, et al. A hyperoxic lung injury model in premature rabbits: the influence of different gestational ages and oxygen concentrations. PLoS One PLoS One. 2014;9. https://doi.org/10.1371/journal.pone.0095844.
Salaets T, Gie A, Jimenez J, Aertgeerts M, Gheysens O, Vande Velde G et al. Local pulmonary drug delivery in the preterm rabbit: feasibility and efficacy of daily intratracheal injections. Am J Physiol Cell Mol Physiol. 2019; 2019;316:L589-L597.
Jiménez J, Richter J, Nagatomo T, Salaets T, Quarck R, Wagennar A et al. Progressive vascular functional and structural damage in a bronchopulmonary dysplasia model in preterm rabbits exposed to hyperoxia. Int J Mol Sci. 2016; 2016;7:1776.
Elhafez EAA, Mohamed GK, Hussein MM. Development of the respiratory acinus in the rabbit lung. 2012;1:14–7.
Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2–intrauterine and early postnatal lung growth. Thorax. 1982;37:580–3.
留言 (0)